treprostinil

Poland

Drugs containing this active substance

  • REMODULIN

    The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 1 mg/ml

    ATC: B01AC21

    Manufacturer: Ferrer Internacional, S.A. Kwizda Pharmadistribution GmbH

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 2.5 mg/ml

    ATC: B01AC21

    Manufacturer: Ferrer Internacional, S.A. Kwizda Pharmadistribution GmbH

  • It is used in the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, and facilitates oxygen uptake by the body.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 5 mg/ml

    ATC: B01AC21

    Manufacturer: Ferrer Internacional, S.A. Kwizda Pharmadistribution GmbH

  • The medicinal product is used in the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 10 mg/ml

    ATC: B01AC21

    Manufacturer: Ferrer Internacional, S.A. Kwizda Pharmadistribution GmbH

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 1 mg/ml

    ATC: B01AC21

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used for the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 2.5 mg/ml

    ATC: B01AC21

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 5 mg/ml

    ATC: B01AC21

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 10 mg/ml

    ATC: B01AC21

    Manufacturer: Betapharm Arzneimittel GmbH

  • This medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, and helps the body take in oxygen.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 1 mg/ml

    ATC: B01AC21

    Manufacturer: SGS Pharma Hungary Kft. Tillomed Malta Limited

  • This medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, facilitates oxygenation of the body, and relieves disease symptoms such as shortness of breath or fatigue.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 2.5 mg/ml

    ATC: B01AC21

    Manufacturer: SGS Pharma Hungary Kft. Tillomed Malta Limited

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, and facilitates oxygen uptake by the body.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 5 mg/ml

    ATC: B01AC21

    Manufacturer: SGS Pharma Hungary Kft. Tillomed Malta Limited

  • This medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity. It helps to lower blood pressure in the pulmonary artery, improves blood flow, and facilitates oxygen uptake by the body.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 10 mg/ml

    ATC: B01AC21

    Manufacturer: SGS Pharma Hungary Kft. Tillomed Malta Limited

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity of this disease.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 1 mg/ml

    ATC: B01AC21

    Manufacturer: AOP Orphan Pharmaceuticals GmbH

  • The medicine is used for the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity of this disease.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 2.5 mg/ml

    ATC: B01AC21

    Manufacturer: AOP Orphan Pharmaceuticals GmbH

  • It is used in the treatment of idiopathic or hereditary pulmonary arterial hypertension in patients with moderate symptom severity. It helps to reduce blood pressure in the pulmonary arteries, improves blood flow, and alleviates disease symptoms such as shortness of breath or fatigue.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 5 mg/ml

    ATC: B01AC21

    Manufacturer: AOP Orphan Pharmaceuticals GmbH

  • The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.

    Form: solution for infusion

    Active substance Dosage
    treprostinil 10 mg/ml

    ATC: B01AC21

    Manufacturer: AOP Orphan Pharmaceuticals GmbH